Antioxidant Effect of Estrogen on Cytomegalovirus-Induced Gene Expression in Coronary Artery Smooth Muscle Cells
Authors:
- 12 December 2000
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (24) , 2990-2996
Abstract
Background—Pathogens infecting the arterial wall with resultant inflammation may contribute to atherogenesis. Human coronary artery smooth muscle cells (SMCs) infected with human cytomegalovirus (CMV) demonstrate a rapid increase in reactive oxygen species (ROSs), with activation of genes involved in viral replication and inflammation. Because estrogen appears to have antioxidant properties, we wished to determine whether this hormone attenuates SMC responses to CMV infection.Methods and Results—Using confocal microscopy and an intracellular fluorescent dye activated by ROSs, we found that 17β-estradiol (0.1 to 10 nmol/L) and its stereoisomer 17α-estradiol (which has low affinity for the estrogen receptor) dose-dependently inhibited ROS generation in CMV-infected SMCs. These effects were not blocked by the estrogen receptor inhibitor ICI 182,780. 3-Methoxyestrone, which lacks the phenolic hydroxyl group, did not interfere with ROS generation. We found that 17β-estradiol and 17α-estradiol, but not 3-methoxyestrone, prevented binding of nuclear factor (NF)-κB to DNA. Furthermore, in SMCs transfected with the reporter constructs 3XκB-CAT, MIEP-CAT, or ICAM-CAT, cotransfection with a CMV-IE72 expression plasmid caused promoter and CAT activation. Treatment with 17β-estradiol and 17α-estradiol, but not 3-methoxyestrone, inhibited CAT activity and, in CMV-infected SMCs, prevented IE72 and ICAM-1 protein expression and cytopathic effects.Conclusions—These findings indicate that estrogen molecules with an A-ring hydroxyl group have estrogen receptor–independent anti-CMV effects at physiological concentrations by inhibiting ROS generation, NF-κB activation, NF-κB–dependent transcription, and viral replication. To the extent that chronic infection of the vascular wall with CMV contributes to atherogenesis, these antioxidant actions of estrogen may be of therapeutic importance.Keywords
This publication has 28 references indexed in Scilit:
- Oxidative Modulation of Cyclic AMP-Dependent Protein Kinase in Human Fibroblasts: Possible Role in PsoriasisFree Radical Biology and Medicine, 1997
- Estradiol protects against β-amyloid (25–35)-induced toxicity in SK-N-SH human neuroblastoma cellsNeuroscience Letters, 1996
- CYTOMEGALOVIRUS INDUCED UP-REGULATION OF LFA-3 (CD58) AND ICAM-1(CD54) IS A DIRECT VIRAL EFFECT THAT IS NOT PREVENTED BY GANCICLOVIR OR FOSCARNET TREATMENT1Transplantation, 1996
- Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial CellsJournal of Biological Chemistry, 1996
- Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-negative Breast Cancer CellsJournal of Biological Chemistry, 1996
- Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary RestenosisScience, 1994
- [60] Tamoxifen and estrogens as membrane antioxidants: Comparison with cholesterol1994
- Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal womenThe Lancet, 1994
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Human cytomegalovirus stimulates arachidonic acid metabolism through pathways that are affected by inhibitors of phospholipase A2 and protein kinase CBiochemical and Biophysical Research Communications, 1990